Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Hepatology. 2022 May 24;77(2):619–639. doi: 10.1002/hep.32562

Fig. 3. Small Molecules Targeting UPR Branches.

Fig. 3.

List of small chemicals for specific targeting of UPR components (129, 130). Given that the majority of these compounds have not been examined in the context of liver diseases, future studies are warranted to examine these compounds in the context of liver disease in both pre-clinical and clinical studies.